Figure 1From: Optimizing antimicrobial prescribing: Are clinicians following national trends in methicillin-resistant staphylococcus aureus (MRSA) infections rather than local data when treating MRSA wound infectionsState Level Prescribing and National MRSA Rates. a. State-level clindamycin prescribing vs. national MRSA rates. b. State-level linezolid prescribing vs. national MRSA rates. c. State-level cephalexin prescribing vs. national MRSA rates. d. State-level trimethoprim/sulfamethoxazole prescribing vs. national MRSA rates. Note: Box and whisker plots represent median, interquartile range and whisker boundaries of monthly antimicrobial prescribing among all states in the IMS Health XponentTM database; line represents monthly national MRSA rates. Source: Author’s calculations with susceptibility information from The Surveillance Network® (TSN) and prescription data derived from IMS Health Xponent™ January 1999-December 2007, IMS Health Incorporated. All Rights Reserved.Back to article page